Levi & Korsinsky is investigating the Board of Directors of Volterra Semiconductor Corporation (“Volterra” or the “Company”) (NasdaqGS: VLTR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Maxim Integrated Products, Inc. (NasdaqGs: MXIM).
Click here to learn more about the investigation http://zlk.9nl.com/volterra-semiconductor-vltr/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Volterra shareholders will receive $23.00 for each share of Volterra stock they own. The investigation concerns whether the Volterra Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Maxim Integrated Products, Inc. is underpaying for Volterra shares.
If you own common stock in Volterra and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/volterra-semiconductor-vltr/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
|Molex Incorporated Shareholder Alert: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Molex Incorporated in Connection with Sale of Company to Koch Industries (2013/9/10)|
|SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Greenway Medical Technologies, Inc. In Connection With Sale Of Company to Vista Equity Partners (2013/9/24)|
|Kaydon Corporation SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Kaydon Corporation in Connection With the Sale of the Company to AB SKF ()|
|MTR GAMING GROUP, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of MTR Gaming Group, Inc. ()|
|ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Onyx Pharmaceuticals, Inc. (2013/8/29)|
|LEVI & KORSINSKY, LLP Investigates WASHINGTON BANKING CO. for Possible Breaches of Fiduciary Duty by Board of Washington Banking Co. In Connection With Sale Of Company to Heritage Financial Corp. ()|
|MERGER UPDATE - HOME FEDERAL BANCORP: Levi & Korsinsky, LLP Investigates Possible Breaches of Fiduciary Duty by Board of Home Federal Bancorp, Inc. In Connection With Sale Of Company to Cascade Bancorp (2013/10/28)|
|SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of World Acceptance Corp. (2013/11/13)|
|Levi & Korsinsky, LLP Investigates ViroPharma, Inc. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC (2013/11/12)|
|SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into DENDREON CORP. Regarding Possible Breaches of Fiduciary Duty (2014/2/25)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.